Lawrence T. Kennedy Jr. - 03 Jan 2023 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director, 10%+ Owner
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Lawrence T. Kennedy, Jr.
Issuer symbol
BDSX
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 20:20:44 UTC
Previous filing
05 Jan 2023
Next filing
25 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +91,463 $0.000000 91,463 03 Jan 2023 Common Stock 91,463 Direct F1, F2, F4
transaction BDSX Restricted Stock Units Award $0 +27,408 $0.000000 27,408 03 Jan 2023 Common Stock 27,408 Direct F1, F3, F4
transaction BDSX Stock Options (Right to Buy) Award $0 +124,998 $0.000000 124,998 03 Jan 2023 Common Stock 124,998 $2.05 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer common stock.
F2 These RSUs will vest in full on January 3, 2024, generally subject to the Reporting Person's continued service on the Issuer's board of directors (the "Board") through the applicable vesting date, and have no expiration date.
F3 These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date, and have no expiration date.
F4 Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer.
F5 This option vests 40% on January 3, 2025, and the remaining 60% in 36 successive, equal monthly installments measured from January 3, 2025, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date.